x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:23:33

Mathai Mammen recaps the first clinical data...

BiotechTV - News ·

2025/10/31

He explains the company's "Helicon" peptide platform, and why he believes it is well suited to target previously undruggable problems like beta-catenin. Then he discusses clinical presentations on this program in multiple tumor types, and preclinical data on two degrader programs for prostate cancer.

en-us

00:13:00

BiotechTV visited South San Francisco based Noetik...

BiotechTV - News ·

2025/10/30

Co-Founder and CEO Ron Alfa walked BiotechTV's Ryan Flinn through how machine learning is taking cancer cell biology beyond the microscope.

en-us

00:23:18

Sonoma Biotherapeutics announced early clinical data...

BiotechTV - News ·

2025/10/30

They explain why they believe a Treg based cell therapy is the right approach for autoimmune conditions, and describe the construct of this particular product. After discussing the data, they also comment on what they believe the big picture is for these types of Treg based treatments going forward.

en-us

00:10:10

Zag Bio launched today with $80M, and aims to tackle...

BiotechTV - News ·

2025/10/28

CEO Jason Cole walks us through this unique science, which is based on work that co-founder Diane Mathis and colleagues published in Cell in 2022. The T1D program is scheduled to be in the clinic by late 2026.

en-us

00:11:21

Hemab Therapeutics, a company specializing in...

BiotechTV - News ·

2025/10/27

The company's lead program, a bi-specific called Sutacimig, has already reported phase 2 data for Glanzmann Thrombasthenia, and will start a pivotal in 2026. Hemab also has a monovalent antibody (HMB-022) in the clinic for the world's most common bleeding disorder, Von Willebrand Disease, and will be announcing an additional candidate next year.

en-us

00:08:41

Weave Bio, which raised a $20M series A this month,...

BiotechTV - News ·

2025/10/23

Co-Founder & CEO Brandon Rice says that in one project it worked on with a pharma, Weave's technology took only 3 hours to draft regulatory documents what would have taken humans to 100 hours.

en-us

00:20:39

Ahead of a year of increased clinical activity,...

BiotechTV - News ·

2025/10/22

He walks us through exon 44 and 45 programs, which will both likely have clinical readouts in 2026. Meanwhile, a $350M cash position gives Entrada the ability to think beyond neuromuscular conditions in the future as well.

en-us

00:23:10

Disc Medicine CEO John Quisel describes the process...

BiotechTV - News ·

2025/10/22

He describes how Disc applied for and was awarded a CNPV for Bitopertin, which treats a rare disease that causes extreme sensitivity to sunlight. Plus, quickly ramping up a commercial team, and discussing Disc's two other development programs.

en-us

00:52:24

Biotech entrepreneurs share advice on navigating...

BiotechTV - News ·

2025/10/22

MassBio CEO Kendalle Burlin O'Connell moderates a discussion with Normunity CEO Rachel Humphrey and Gallop Oncology CEO Luba Greenwood about how they are rising to today's challenges. Topics include the funding environment, motivating your team, storytelling, FDA Engagement, and perseverance.

en-us

00:09:37

Flagship Pioneering announced its newest company to...

BiotechTV - News ·

2025/10/22

Co-Founder and CEO Molly Gibson explains the science behind the new company and the technology and equipment it uses for the work. Expedition has been funded with $50 million, and is also announcing a multi-target deal with Pfizer for prostate cancer.

en-us

00:15:13

Biotech veteran Oz Azam has become the CEO of Cue...

BiotechTV - News ·

2025/10/21

He describes CUE-401, which combines a TGF-beta breathing-mask moiety with an interleukin (IL-2) mutein, and CUE-501, a Boehringer Ingelheim partnered program which is designed to deplete B-cells by painting them and engaging with virus-specific memory T-cells.

en-us

00:14:57

Get to know Women In Bio, and how this organization...

BiotechTV - News ·

2025/10/21

During a meeting in Boston at Portal Innovations where Women in Bio (WIB) was working on its 'Boardroom Ready' initiative, Dianne Keen-Kim (National President and Board Chair), Gina Ford (CEO), and Katherine Andersen (Board Member) discuss how WIB helps women in our industry today and its goals for the future.

en-us

00:21:17

Emeryville, CA based Profusa is developing an...

BiotechTV - News ·

2025/10/16

Chairman & CEO Ben Hwang describes the idea behind Profusa's approach, and how he believes it delivers more robust and actionable information than purely surface based tools such as the Apple Watch.

en-us

00:24:42

PepGen's CEO James McArthur gives an overview of the...

BiotechTV - News ·

2025/10/15

He describes the science behind PepGen's "Enhanced Delivery Oligonucleotide (EDO)" platform, and explain how he believes it gives the company a differentiated advantage in this condition by focusing on the pathogenic repeat that causes DM1 and restoring normal function.

en-us

00:07:37

Benchtalk 2025: Kate Haviland discusses the $9B+...

BiotechTV - News ·

2025/10/14

The CEO of Blueprint (up to the acquisition) discusses the company's success factors, and being led to immunology by the science. Plus, why she believes an oral pill that is disease modifying, like Fulcrum is trying to develop, is strongly needed for the sickle cell patient community.

en-us

00:07:54

Benchtalk 2025: Generate:Biomedicines' VP of...

BiotechTV - News ·

2025/10/14

He walks us through the design, build, test, learn model that is the foundation of Generate's approach to drug development.

en-us

00:05:15

Benchtalk 2025: Benchling Co-Founder & CEO Sajith...

BiotechTV - News ·

2025/10/14

He welcomes us to Benchtalk 2025, which had more than 800 scientists register this year, and describes how AI and other computational advances are allowing scientists to focus on increasing the speed and reducing the cost of R&D.

en-us

00:10:04

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra...

BiotechTV - News ·

2025/10/14

He describes the science behind FORCE, which combines an antigen-binding fragment, a linker and, a payload. The company's DMD program will have a key trial readout before the end of this year, and DM1 will follow in 2026. Both programs could be filed for AA in 2026 with positive data.

en-us

00:13:24

Sunrise Group, which has designed a mandibular sensor...

BiotechTV - News ·

2025/10/10

Co-Founder & CEO Laurent Martinot discusses the raise, and the need for more accessible sleep health care. Plus, previewing a clinical trial of its device that will read out shortly.

en-us

00:16:54

Oxford's OrganOx became one of the UK's biggest news...

BiotechTV - News ·

2025/10/10

CEO Craig Marshall describes how the company's "metra" device pumps blood through donor organs (currently livers) in order to extend the amount of time they can be transplanted safely.

en-us

267 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter